DURECT Corp (DRRX) CEO James Brown on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/05/22
DURECT Corporation Reports First Quarter 2022 Financial Results and Update of ProgramsPRNewsWire • 05/04/22
DURECT Corporation to Announce First Quarter 2022 Financial Results and Provide Business Update on May 4PRNewsWire • 04/27/22
DURECT Corporation To Present at the 2022 Cantor Fitzgerald Virtual Rare Orphan Disease SummitPRNewsWire • 03/23/22
DURECT Corporation Fireside Chat at the Oppenheimer 32nd Annual Healthcare ConferencePRNewsWire • 03/09/22
DURECT Corporation's (DRRX) CEO Jim Brown on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/08/22
DURECT Corporation Reports Fourth Quarter and Full Year 2021 Financial Results and Update of ProgramsPRNewsWire • 03/07/22
DURECT Corporation Doses First European Patient in Phase 2b AHFIRM Study of Larsucosterol(DUR-928) in Severe Alcohol-Associated HepatitisPRNewsWire • 03/01/22
DURECT Corporation to Announce Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on March 7PRNewsWire • 02/28/22
Here's Why Durect (DRRX) is Poised for a Turnaround After Losing 17.1% in 4 WeeksZacks Investment Research • 01/13/22
DURECT and Innocoll Announce a $136 Million U.S. Licensing Agreement for POSIMIR® (Bupivacaine Solution)PRNewsWire • 12/22/21
DURECT Corporation Expands Board of Directors with Appointment of Biopharmaceutical Industry Finance Veteran Peter GarciaPRNewsWire • 12/14/21
DURECT Corporation to Participate in Alcoholic Liver Disease Workshop Today at the 5th Annual NASH SummitPRNewsWire • 11/29/21
Data Presentation Today at The Liver Meeting® 2021 Shows Increasing Hospital Admissions for Alcohol-Associated Hepatitis (AH) in the U.S.PRNewsWire • 11/12/21
DURECT Corporation Doses First ex-U.S. Patient in Phase 2b AHFIRM Study of Larsucosterol (DUR-928) in Severe Alcohol-Associated HepatitisPRNewsWire • 11/10/21
DURECT Corporation Announces Poster Presentation on the Prevalence of Hospitalized Alcohol-Associated Hepatitis (AH) Patients in the U.S. to be Presented at The Liver Meeting® 2021PRNewsWire • 11/08/21
DURECT Corporation (DRRX) CEO Jim Brown on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/03/21
DURECT Corporation Reports Third Quarter 2021 Financial Results and Update of ProgramsPRNewsWire • 11/02/21
DURECT Corporation to Announce Third Quarter 2021 Financial Results and Provide Business Update on November 2PRNewsWire • 10/26/21
Will Durect (DRRX) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 10/25/21
DURECT Corporation Fireside Chat at the H.C. Wainwright 5th Annual NASH Investor ConferencePRNewsWire • 10/07/21